Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adolfo Ferrando

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Best Practice & Research. Clinical Haematology|November 24, 2018
Can one target T-cell ALL?Adolfo Ferrando
Clinical Lymphoma & Myeloma|September 26, 2009
Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemiaTeresa Palomero, Adolfo Ferrando
Nature Reviews. Cancer|July 26, 2016
The genetics and mechanisms of T cell acute lymphoblastic leukaemiaLaura Belver, Adolfo Ferrando
Blood Reviews|October 23, 2010
Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemiaMaddalena Paganin, Adolfo Ferrando
Genes & Development|November 3, 2019
Metabolic dependencies and vulnerabilities in leukemiaMarissa Rashkovan, Adolfo Ferrando
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomasTeresa Palomero, Adolfo Ferrando
The Journal of Clinical Investigation|October 2, 2012
The molecular basis of T cell acute lymphoblastic leukemiaPieter Van Vlierberghe, Adolfo Ferrando
Blood|January 25, 2017
The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemiaMarta Sanchez-Martin, Adolfo Ferrando
Blood|March 27, 2019
Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALLChelsea L Dieck, Adolfo Ferrando
Cancer Cell|December 12, 2018
Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: BIM FinallyJessie A Brown, Adolfo Ferrando
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Best Practice & Research. Clinical Haematology|November 24, 2018
Can one target T-cell ALL?Adolfo Ferrando
Clinical Lymphoma & Myeloma|September 26, 2009
Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemiaTeresa Palomero, Adolfo Ferrando
Nature Reviews. Cancer|July 26, 2016
The genetics and mechanisms of T cell acute lymphoblastic leukaemiaLaura Belver, Adolfo Ferrando
Blood Reviews|October 23, 2010
Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemiaMaddalena Paganin, Adolfo Ferrando
Genes & Development|November 3, 2019
Metabolic dependencies and vulnerabilities in leukemiaMarissa Rashkovan, Adolfo Ferrando
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomasTeresa Palomero, Adolfo Ferrando
The Journal of Clinical Investigation|October 2, 2012
The molecular basis of T cell acute lymphoblastic leukemiaPieter Van Vlierberghe, Adolfo Ferrando
Blood|January 25, 2017
The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemiaMarta Sanchez-Martin, Adolfo Ferrando
Blood|March 27, 2019
Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALLChelsea L Dieck, Adolfo Ferrando
Cancer Cell|December 12, 2018
Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: BIM FinallyJessie A Brown, Adolfo Ferrando
Pageof 5